Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc. · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
adult adhd, centanafadine sustained release, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806025
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.